Clinical Trial Update: Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression [Phase 2]

View source ↗

Summary

Phase 2 trial update of pulsed Abraxane (paclitaxel protein-bound) with radiotherapy for cancer-related spinal cord compression; the study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Spinal Cord Compression

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cord Compression | Phase 2 | Status: TERMINATED | Results posted: 2021-10-18